Cancer Research Annual Meeting 2010 Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 4506-4509, September 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyaki, M.
Right arrow Articles by Kuroki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyaki, M.
Right arrow Articles by Kuroki, T.
[Cancer Research 59, 4506-4509, September 15, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Frequent Mutation of ß-Catenin and APC Genes in Primary Colorectal Tumors from Patients with Hereditary Nonpolyposis Colorectal Cancer1

Michiko Miyaki2, Takeru Iijima, Junko Kimura, Masamichi Yasuno, Takeo Mori, Yukiko Hayashi, Morio Koike, Nobuyuki Shitara, Takeo Iwama and Toshio Kuroki

Hereditary Tumor Research Project [M. M., T. Ii., J. K.] and Departments of Surgery [M. Y., T. M.], Pathology [Y. H., M. K.], and Neurosurgery [N. S.], Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677; Kyoundo Hospital Sasaki Institute, Tokyo 101-0062 [T. Iw.]; and Institute of Molecular Oncology, Showa University, Tokyo 142-8555 [M. M., T. Ii., T. K.], Japan.


   ABSTRACT
Top
 ABSTRACT
Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
Hereditary nonpolyposis colorectal cancer (HNPCC) is characterized by defective DNA mismatch repair, which results in genetic instability of tumors; however, only a few target genes have been recognized. Our previous study detected a low frequency of APC gene mutation (21%) in colorectal tumors from HNPCC patients, in contrast to a high frequency of APC gene alteration (>70%) in non-HNPCC tumors. Because both ß-catenin and ACP gene mutations have recently been shown to activate the same signaling pathway, we analyzed ß-catenin mutation in HNPCC tumors. A notable frequency of ß-catenin gene mutation (43%, 12 of 28) was found to occur in HNPCC colorectal tumors. ß-Catenin mutations were not detected in tumors with APC mutations. All ß-catenin mutations detected in HNPCC tumors existed within the regulatory domain of ß-catenin. Immunohistochemical staining of tumors with this mutation showed accumulation of ß-catenin protein in nuclei. These and previous data from our laboratory suggest that activation of the ß-catenin-Tcf signaling pathway, through either ß-catenin or APC mutation, contributes to HNPCC colorectal carcinogenesis in ~65% of cases.


   Introduction
Top
 ABSTRACT
 Introduction
Materials and Methods
 Results and Discussion
 REFERENCES
 
HNPCC3 (1) is principally characterized by inactivation of DNA mismatch repair genes, resulting in high replication error at microsatellite loci (2, 3, 4, 5, 6, 7) as well as at repeated sequences in coding regions, such as (A)10 in TGRßRII (8) and (G)8 in BAX genes (9) . In some patients, a small number of adenomatous polyps can be found in colorectal tissues, in addition to carcinomas (10) . However, the molecular mechanisms by which tumors are developed in HNPCC patients have not yet been fully elucidated. We have previously demonstrated that the molecular nature of HNPCC tumors with severe (high) replication error at microsatellite loci (MSI-H) is quite different from that of FAP and sporadic cases with low MSI or without MSI: the frequency of APC gene mutation was found to be low (~20%) in tumors from HNPCC patients (6) but high in non-HNPCC tumors, in which >70% of cases had mutation and/or loss of heterozygosity (LOH) (11) .

It is known that wild-type APC protein forms a complex with ß-catenin and GSK3ß, inducing degradation of ß-catenin in normal cells, whereas in tumor cells, mutant APC protein lacks the ability of complex formation and ß-catenin accumulates in nuclei (12 , 13) . This causes interaction of ß-catenin with the nuclear transcription factor (Lef/Tcf) family, resulting in activation of target genes, including cyclin D1 (14 , 15) . Similar accumulation of ß-catenin has been demonstrated in colorectal carcinoma cell lines without APC mutations but with mutations in the regulatory domain (codons 29–48) of the ß-catenin gene, suggesting that activation of the ß-catenin-Tcf signaling pathway by mutation in either the APC or ß-catenin gene contributes to colorectal carcinogenesis (16) . Such activating mutations of the ß-catenin gene have occurred in some sporadic primary colorectal tumors (17, 18, 19) and in various other tumors. These results imply that, in addition to its function as a cell adhesion protein associating with E-cadherin, ß-catenin acts as a potential oncogene. To assess the possible contribution of this signaling pathway in HNPCC carcinogenesis, we analyzed ß-catenin mutation in colorectal tumors from HNPCC patients.


   Materials and Methods
Top
 ABSTRACT
 Introduction
 Materials and Methods
Results and Discussion
 REFERENCES
 
Tumor Samples.
Twenty-eight primary colorectal tumors, including 23 invasive carcinomas, 2 intramucosal carcinomas, 2 adenomas, and 1 hyperplastic polyp, were obtained from 18 patients in Japanese HNPCC families (Table 1)Citation . These families included 9 cases with germ-line mutations of the hMSH2, hMLH1, and hMSH6 genes (6 , 7 , 20) and 9 cases who had no identified germ-line mutation but fulfilled the Amsterdam criteria for HNPCC, according to the following definitions: (a) at least three family members with colorectal carcinoma, two of whom were first-degree relatives; (b) at least two generations were represented; and (c) at least one individual was younger than 50 years of age at diagnosis (1) . Almost all tumors (27 of 28) exhibited severe (high) replication error at microsatellite loci (MSI-H), as reported previously (6 , 7 , 20) , and one tumor showed low MSI. As summarized in Table 1Citation , six of these tumors had APC gene mutations, as described in our previous report (6) . Forty primary colorectal tumors from FAP, 45 sporadic tumors with APC mutation, and 36 sporadic tumors without APC mutation were included in previous reports (6 , 11) .


View this table:
[in this window]
[in a new window]

  		Table 1 Mutations of ß-catenin, APC, and TGFßRII genes in tumors from HNPCC patientsa

 
Mutation Analysis of ß-catenin gene.
Genomic DNA samples from tumors and the corresponding normal tissues were extracted using proteinase K and chloroform-phenol. DNA samples were amplified for single-strand conformation polymorphism (SSCP) analysis of the ß-catenin gene using PCR under the same conditions as reported previously for APC and mismatch repair genes (6 , 11) . Primers used to amplify exon 3 of the ß-catenin gene were the same as those reported (21) . When abnormal bands were detected in the SSCP analysis, single-stranded DNA fragments were extracted, amplified by asymmetrical PCR, and then subjected to direct sequencing by dideoxy chain-termination reaction as described previously (11) .

Immunohistochemical Analysis.
Immunohistochemical staining was performed on formalin-fixed, paraffin-embedded tumor tissues by the avidin-biotin complex method. Sections of tumor tissues on glass slides were dried, deparaffinized, and stained using mouse antihuman ß-catenin monoclonal antibody clone 14 (Transduction Laboratories, Lexington, KY).


   Results and Discussion
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
REFERENCES
 
Exon 3 of the ß-catenin gene contains the regulatory domain of ß-catenin, of which mutations have been detected in various sporadic tumors, resulting in its nuclear accumulation. In this study, mutation of this exon was analyzed in genomic DNA of 28 colorectal tumors from HNPCC patients with germ-line and/or somatic mutations of hMSH2, hMLH1, and hMSH6 genes (6 , 7 , 20) and from patients in families fulfilling the Amsterdam criteria for HNPCC. In the PCR-SSCP analysis, DNA fragments of aberrant bands detected in tumor DNA but not in corresponding normal tissue DNA were further amplified by asymmetrical PCR, followed by direct sequencing (Fig. 1)Citation .



View larger version (56K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. Nucleotide sequences of the ß-catenin gene in DNAs from a colorectal carcinoma and corresponding normal tissue. ACC -> GCC mutation at codon 41 is present in carcinoma HNP8CoCa from an HNPCC patient with germ-line mutation of hMLH1.

 
Somatic ß-catenin gene mutations were detected in 12 HNPCC colorectal tumors, including 11 carcinomas and 1 adenoma, in which no APC gene mutation was detected (Table 1)Citation . These mutations were single-base substitutions that were located within the NH2-terminal regulatory domain of ß-catenin (codons 29–48): TCT (Ser) -> TTT (Phe), CCT (Pro), or TGT (Cys) at codon 45; ACC (Thr) -> GCC (Ala) at codon 41; TCT (Ser) -> TGT (Cys) at codon 37; GGA (Gly) -> GAA (Glu) at codon 34; GAC (Asp) -> GGC (Gly) or TAC (Tyr) at codon 32; and a 3-bp deletion at codon 43. One carcinoma (HNP15CoCa) had two of these mutations in one allele. All the mutations occurred at the same codons as those previously detected in sporadic colorectal and other tumors, and 75% (9 of 12) of single-base substitutions were transition type.

Immunohistochemical staining of HNPCC carcinomas with ß-catenin mutation showed a high level of ß-catenin protein in both cytoplasm and nuclei, with stronger staining in the nuclei, although in normal epithelial cells of the colon ß-catenin protein was localized in the membrane but not in the nuclei (Fig. 2)Citation . This implies that the mutated ß-catenin is accumulated in nuclei and may result in activation of transcription of specific genes as proposed (13, 14, 15, 16) .



View larger version (107K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 2. Immunohistochemical staining of ß-catenin protein in colorectal carcinoma tissue with ß-catenin gene mutation and normal mucosa of the colon, using antihuman ß-catenin antibody. A, carcinoma (HNP8CoCa); staining of ß-catenin protein is observed in both cytoplasm and nuclei, with stronger staining in the nuclei. B, normal mucosa of the colon; ß-catenin protein is localized in the membrane but not in the nuclei.

 
In this study, ß-catenin mutation was not detected in six HNPCC tumors with APC mutations (Tables 1Citation and 2)Citation , 45 sporadic colorectal tumors with APC gene alterations (mutation and/or LOH), or 40 colorectal tumors from patients with FAP. Alternatively, APC mutation was not detected in 12 HNPCC colorectal tumors with ß-catenin mutations (Table 1Citation and 2)Citation . Consistent with this observation, absence of ß-catenin mutation has been reported in sporadic colorectal tumors with APC mutation (19) . Such alternate exclusion was also observed between p53 mutation and BAX mutation in these HNPCC tumors (data not shown). However, mutations in the TGFßRIIgene were coexistent in 9 of 12 HNPCC tumors with mutations of ß-catenin (Table 1)Citation . Coexistence of mutations of TGRßRII and APC was also observed in two of six HNPCC tumors with APC mutations. These results suggest the possibility that TGRßRII mutation, which frequently occurs following replication error in HNPCC tumors at an early stage of tumorigenesis (6 , 7) , does not substitute for the activated ß-catenin-Tcf signaling pathway.


View this table:
[in this window]
[in a new window]

  		Table 2 Summary of ß-catenin and APC mutations in tumors from HNPCC patients

 
HNPCC patients intrinsically have a germ-line mutation in one allele of a mismatch repair gene, and a single hit to the remaining allele inactivates of this gene. Accordingly, HNPCC patients are liable to defects in mismatch repair, which results in MSI and an elevated frequency of mutations in various genes (22) . Spectra of spontaneous mutations have recently been determined by mutation at the hprt locus in colorectal cell lines deficient in mismatch repair and showing the MSI-H phenotype (23 , 24) . Mutation frequency in these cells was 2 orders higher than that in wild-type repair-proficient cells: both single-base substitutions (57 and 66%) and frameshifts (43 and 28%) occurred in hMLH1- and an hPMS2-deficient cell lines, respectively, whereas single-base substitution (92%) was preferentially observed in an hMSH6-deficient cell line. These data suggest that frequent single-base substitution of ß-catenin detected in this study (4.3%; 12 of 28) may be due to MSI of HNPCC tumors, although a rather low frequency of this mutation (10%, 1 of 10) has previously been observed in other HNPCC cases (17) . In contrast, sporadic primary colorectal tumors show much lower mutation frequencies of the ß-catenin gene, ranging from 1 to 15% (17, 18, 19) ; this value was 4% (3 of 81) in our study.

The frequency of APC gene mutation in HNPCC tumors was lower (~20%) than alteration of this gene in sporadic tumors (>70%). One possible explanation is that inactivation of the APC gene by mutation plus LOH occurs at a high frequency in sporadic colorectal tumors, but LOH is very rare at various chromosomal regions in HNPCC tumors (3 , 6) . The APC gene has many A-repeat regions, but the number of repeats in each region is not more than six, compared to (A)10 in TGRßRII, which may also be a reason for infrequent frameshift mutation in the APC gene, even in HNPCC tumors with the MSI-H phenotype.

We conclude from these findings that either activating mutation of ß-catenin or inactivating mutation of APC may significantly contribute to HNPCC colorectal carcinogenesis. Because mutations in either APC or ß-catenin have been known to be associated with adenoma formation, this observation may imply that more than half of HNPCC carcinomas develop via the adenoma-carcinoma sequence. Further analysis of genetic changes in HNPCC may be important for full understanding of the mechanisms of colorectal carcinogenesis in humans.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by the Project "High-Technology Research Center" from the Ministry of Education, Science, Sport and Culture of Japan. Back

2 To whom requests for reprints should be addressed, at Hereditary Tumor Research Project, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan. Phone: 81-3-3823-2101 ext. 4425; Fax: 81-3-3823-5433; E-mail: mmiyaki{at}opal.famille.ne.jp Back

3 The abbreviations used are: HNPCC, hereditary nonpolyposis colorectal cancer; MSI, microsatellite instability; FAP, familial adenomatous polyposis; LOH, loss of heterozygosity; SSCP, single-stranded conformation polymorphism. Back

Received 5/24/99. Accepted 8/ 2/99.


   REFERENCES
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 

  1. Lynch H. T., Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An update review. Cancer (Phila.), 78: 1149-1167, 1996.[Medline]
  2. Ionov Y., Peinado M. A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.), 363: 558-561, 1993.[Medline]
  3. Aaltonen L. A., Petromäki P., Leach F. S., Sistonen P., Pylkkänen L., Mecklin J-P., Järvinen H., Powell S. M., Jen J., Hamilton S. R., Petersen G. M., Kinzler K. W., Vogelstein B., de la Chapelle A. Clues to the pathogenesis of familial colorectal cancer. Science (Washington DC), 260: 812-816, 1993.[Abstract/Free Full Text]
  4. Fishel R., Lescoe M. K., Rao M. R. S., Copeland N. G., Jenkins N. A., Garber J., Kane M., Kolodner R. The human mutator gene homolog of MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75: 1027-1038, 1993.[Medline]
  5. Leach F. S., Nicolaides N. C., Papadopoulos N., Liu B., Jen J., Parsons R., Petromäki P., Sistonen P., Aaltonen L. A., Nyström-Lahti M., Guan X-Y., Zhang J., Meltzer P. S., Yu J-W., Kao F-T., Chen D. J., Cerosaletti K. M., Fournier P. E. K., Todd S., Lewis T., Leach R. J., Naylor S. L., Weissenbach J., Mecklin J-P., Järvinen H., Petersen G. M., Hamilton S. R., Green J., Jass J., Watson P., Lynch H. T., Trent J. M., de la Chapelle A., Kinzler K. W., Vogelstein B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75: 1215-1225, 1993.[Medline]
  6. Konishi M., Kikuchi-Yanoshita R., Tanaka K., Muraoka M., Onda A., Okumura Y., Kishi N., Iwama T., Mori T., Koike M., Ushio K., Chiba M., Nomizu S., Konishi F., Utsunomiya J., Miyaki M. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology, 111: 307-317, 1996.[Medline]
  7. Miyaki M., Konishi M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Yasuno M., Igari T., Koike M., Chiba M., Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat. Genet., 17: 271-272, 1997.[Medline]
  8. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L-Z., Luttenbaugh J., Fan R. S., Zborowska E., Kinzler K. W., Vogelstein B., Brattain M., Willson J. K. V. Inactivation of the type II TGF-ß receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.[Abstract/Free Full Text]
  9. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J. C., Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science (Washington, DC), 275: 967-969, 1997.[Abstract/Free Full Text]
  10. Jass J. R., Stewart S. M. Evolution of hereditary non-polyposis colorectal cancer. Gut, 33: 783-786, 1992.[Abstract/Free Full Text]
  11. Miyaki M., Konishi M., Kikuchi-Yanoshita R., Enomoto M., Igari T., Tanaka K., Muraoka M., Takahashi H., Amada Y., Fukayama M., Maeda Y., Iwama T., Mishima Y., Mori T., Koike M. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res., 54: 3011-3020, 1994.[Abstract/Free Full Text]
  12. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., Polakis P. Binding to the APC-ß-catenin complex and regulation of complex assembly. Science (Washington, DC), 272: 1023-1026, 1996.[Abstract]
  13. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P. Regulation of intracellular ß-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA, 92: 3046-3050, 1995.[Abstract/Free Full Text]
  14. Kornik V., Barker N., Morin P. J., van Wichen D., de Weger R., Kinzler K. W., Vogelstein B., Clevers H. Constitutive transactivation by a ß-catenin-Tcf complex in ASPC-/- colon carcinoma. Science (Washington, DC), 275: 1784-1787, 1997.[Abstract/Free Full Text]
  15. Tetsu O., McCormick F. ß-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.[Medline]
  16. Morin P. J., Sparks A. B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K. W. Activation of ß-catenin-Tcf signaling in colon cancer by mutation in ß-catenin or APC. Science (Washington, DC), 275: 1787-1790, 1997.[Abstract/Free Full Text]
  17. Kitaeva M. N., Grogan L., Williams J. P., Dimond E., Nakahara K., Hauser P., DeNobile J. W., Soballe P. W., Kirsch I. R. Mutations in ß-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res., 57: 4478-4481, 1997.[Abstract/Free Full Text]
  18. Iwao K., Nakamori S., Kameyama M., Imaoka S., Kinoshita M., Fukui T., Ishiguro S., Nakamura Y., Miyoshi Y. Activation of the ß-catenin gene interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res., 58: 1021-1026, 1998.[Abstract/Free Full Text]
  19. Sparks A. B., Morin P. J., Vogelstein B., Kinzler K. W. Mutational analysis of the APC/ß-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58: 1130-1134, 1998.[Abstract/Free Full Text]
  20. Miyaki M., Konishi M., Muraoka M., Kikuchi-Yanoshita R., Tanaka K., Iwama T., Mori T., Koike M., Ushio K., Chiba M., Nomizu S., Utsunomija J. Germline mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J. Mol. Med., 73: 515-520, 1995.[Medline]
  21. Voeller H. J., Truica C. I., Gelmann E. P. ß-Catenin mutation in human prostate cancer. Cancer Res., 58: 2520-2523, 1998.[Abstract/Free Full Text]
  22. Loeb L. A. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res., 54: 5059-5063, 1994.[Free Full Text]
  23. Ozeki S., Tachibana A., Tatsumi K., Kato T. Spectra of spontaneous mutations at the hprt locus in colorectal carcinoma cell lines defective in mismatch repair. Carcinogenesis (Lond.), 18: 1127-1133, 1997.[Abstract/Free Full Text]
  24. Kato T., Yatagai F., Glickman B. W., Tachibana A., Ikenega M. Specificity of mutations in the PMS2-deficient human tumor cell line HEC-1-A. Mutat. Res., 422: 279-283, 1998.[Medline]



This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
H. Prenen, J. De Schutter, B. Jacobs, W. De Roock, B. Biesmans, B. Claes, D. Lambrechts, E. Van Cutsem, and S. Tejpar
PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer
Clin. Cancer Res., May 1, 2009; 15(9): 3184 - 3188.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. Sinner, J. J. Kordich, J. R. Spence, R. Opoka, S. Rankin, S.-C. J. Lin, D. Jonatan, A. M. Zorn, and J. M. Wells
Sox17 and Sox4 Differentially Regulate {beta}-Catenin/T-Cell Factor Activity and Proliferation of Colon Carcinoma Cells
Mol. Cell. Biol., November 15, 2007; 27(22): 7802 - 7815.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Sanchez-de-Abajo, M. de la Hoya, M. van Puijenbroek, A. Tosar, J.A. Lopez-Asenjo, E. Diaz-Rubio, H. Morreau, and T. Caldes
Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways
Clin. Cancer Res., October 1, 2007; 13(19): 5729 - 5735.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
W. S. Samowitz, M. L. Slattery, C. Sweeney, J. Herrick, R. K. Wolff, and H. Albertsen
APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer
Mol. Cancer Res., February 1, 2007; 5(2): 165 - 170.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
F. Souaze, V. Viardot-Foucault, N. Roullet, M. Toy-Miou-Leong, A. Gompel, E. Bruyneel, E. Comperat, M. C Faux, M. Mareel, W. Rostene, et al.
Neurotensin receptor 1 gene activation by the Tcf/{beta}-catenin pathway is an early event in human colonic adenomas
Carcinogenesis, April 1, 2006; 27(4): 708 - 716.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Camps, G. Armengol, J. del Rey, J. J. Lozano, H. Vauhkonen, E. Prat, J. Egozcue, L. Sumoy, S. Knuutila, and R. Miro
Genome-wide differences between microsatellite stable and unstable colorectal tumors
Carcinogenesis, March 1, 2006; 27(3): 419 - 428.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
V Johnson, E Volikos, S E Halford, E T Eftekhar Sadat, S Popat, I Talbot, K Truninger, J Martin, J Jass, R Houlston, et al.
Exon 3 {beta}-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome
Gut, February 1, 2005; 54(2): 264 - 267.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Ougolkov, B. Zhang, K. Yamashita, V. Bilim, M. Mai, S. Y. Fuchs, and T. Minamoto
Associations Among {beta}-TrCP, an E3 Ubiquitin Ligase Receptor, {beta}-Catenin, and NF-{kappa}B in Colorectal Cancer
J Natl Cancer Inst, August 4, 2004; 96(15): 1161 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Ouko, T. R. Ziegler, L. H. Gu, L. M. Eisenberg, and V. W. Yang
Wnt11 Signaling Promotes Proliferation, Transformation, and Migration of IEC6 Intestinal Epithelial Cells
J. Biol. Chem., June 18, 2004; 279(25): 26707 - 26715.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Bordonaro, D. L. Lazarova, and A. C. Sartorelli
Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells
Nucleic Acids Res., May 11, 2004; 32(8): 2660 - 2674.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Calabrese, J.-L. Tsao, Y. Yatabe, R. Salovaara, J.-P. Mecklin, H. J. Jarvinen, L. A. Aaltonen, S. Tavare, and D. Shibata
Colorectal Pretumor Progression Before and After Loss of DNA Mismatch Repair
Am. J. Pathol., April 1, 2004; 164(4): 1447 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. G. Daidone, A. Costa, M. Frattini, D. Balestra, L. Bertario, M. A. Pierotti, B. M. Boman, T. Zhang, and J. Z. Fields
Correspondence re: T. Zhang et al., Evidence That APC Regulates Survivin Expression: A Possible Mechanism Contributing to the Stem Cell Origin of Colon Cancer. Cancer Res., 61: 8664-8667, 2001.
Cancer Res., January 15, 2004; 64(2): 776 - 779.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
K.-J. Sohn, M. Choi, J. Song, S. Chan, A. Medline, S. Gallinger, and Y.-I. Kim
Msh2 deficiency enhances somatic Apc and p53 mutations in Apc+/-Msh2-/- mice
Carcinogenesis, February 1, 2003; 24(2): 217 - 224.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
J R Jass, M Barker, L Fraser, M D Walsh, V L J Whitehall, B Gabrielli, J Young, and B A Leggett
APC mutation and tumour budding in colorectal cancer
J. Clin. Pathol., January 1, 2003; 56(1): 69 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Miyaki, T. Iijima, R. Ishii, Y. Kita, M. Koike, T. Kuroki, and T. Mori
Increased Frequency of p53 Mutation in Sporadic Colorectal Cancer from Cigarette Smokers
Jpn. J. Clin. Oncol., June 1, 2002; 32(6): 196 - 201.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. A. C. S. Wong and M. Pignatelli
{beta}-Catenin--A Linchpin in Colorectal Carcinogenesis?
Am. J. Pathol., February 1, 2002; 160(2): 389 - 401.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. P.A. Ebert, G. Fei, S. Kahmann, O. Muller, J. Yu, J. J.Y. Sung, and P. Malfertheiner
Increased {beta}-catenin mRNA levels and mutational alterations of the APC and {beta}-catenin gene are present in intestinal-type gastric cancer
Carcinogenesis, January 1, 2002; 23(1): 87 - 91.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
K. A. Silverman, R. Koratkar, L. D. Siracusa, and A. M. Buchberg
Identification of the Modifier of Min 2 (Mom2) Locus, a New Mutation That Influences Apc-Induced Intestinal Neoplasia
Genome Res., January 1, 2002; 12(1): 88 - 97.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
J R Jass, K Shitoh, F Konishi, T Furukawa, H Nagai, M Miyaki, T Iijima, and T Tsukamoto
Microsatellite unstable colorectal cancer
J. Clin. Pathol., July 1, 2001; 54(7): 573 - 574.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Srivastava, M. Verma, and D. E. Henson
Biomarkers for Early Detection of Colon Cancer
Clin. Cancer Res., May 1, 2001; 7(5): 1118 - 1126.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. Maiti, R. Alam, C. I. Amos, and V. Huff
Frequent Association of {beta}-Catenin and WT1 Mutations in Wilms Tumors
Cancer Res., November 1, 2000; 60(22): 6288 - 6292.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
P. Polakis
Wnt signaling and cancer
Genes & Dev., August 1, 2000; 14(15): 1837 - 1851.
[Full Text]

Home page
 J. Cell Sci.Home page
J Behrens
Cross-regulation of the Wnt signalling pathway: a role of MAP kinases
J. Cell Sci., January 3, 2000; 113(6): 911 - 919.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyaki, M.
Right arrow Articles by Kuroki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyaki, M.
Right arrow Articles by Kuroki, T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online